$Olam Group (VC2.SG)$ 1.13 on paying $3.5 mil to CFTC. Ref: Olam agrees to pay US$3.3 mil in settlement with Commodity Futures Trading Commission
1
1
skc2021
liked
The senior notes will carry a coupon of 3.83% per annum, payable semi-annually in arrear.
Frasers Logistics & Commercial Trust (FLCT) BUOU has priced a $175 million 5-year bond which will be issued on March 26.
Guaranteed by Perpetual (Asia) in its capacity as trustee of FLCT, the senior notes will carry a coupon of 3.83% per annum, payable semi-annually in arrear, and will mature on March 26, 2029.
The issue has an expected and ...
Frasers Logistics & Commercial Trust (FLCT) BUOU has priced a $175 million 5-year bond which will be issued on March 26.
Guaranteed by Perpetual (Asia) in its capacity as trustee of FLCT, the senior notes will carry a coupon of 3.83% per annum, payable semi-annually in arrear, and will mature on March 26, 2029.
The issue has an expected and ...
1
$Tesla (TSLA.US)$ usd220.110. Cited production challenge for the unique design, may take time to reach cash flow positive for Cybertruck, and faced challenges and delays since 2019.
Reference
1. https://www.businessinsider.com/elon-musk-says-cybertruck-faces-enormous-production-challenges-tesla-2023-10
Reference
1. https://www.businessinsider.com/elon-musk-says-cybertruck-faces-enormous-production-challenges-tesla-2023-10
1
2
$Pacific Biosciences of California (PACB.US)$ usd 8.04. it was unfortunate that PacBio could not move to profit since 2007. The only time it got surplus was the payment by Illumina for the terminated merger. Sigh.
1
$Pfizer (PFE.US)$ usd 38.30. Pfizer's lotiglipron dropped, danuglipron still in the test pipeline for obesity drug. Alternative includes Novo Nordisk's Ozempic which is also at mid-stage testing (ref. 1).
Ref
1. https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-discontinue-development-obesity-drug-2023-06-26/
Ref
1. https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-discontinue-development-obesity-drug-2023-06-26/
$BioNTech (BNTX.US)$ usd 126.58 2023 sales expected to be lower due to tapering demand for Covid-19 vaccine (ref fiercepharma.com). several lawsuits: This year, Arbutus Biopharma to file patent lawsuit against Pfizer & BioNTech over Covid vaccines (ref. Reuter). In 2022, Moderna and Alnylam respectively sued Pfizer/BioNTech for patent infringement. Any good news? Jan 2023 BioNTech partnered with UK Government to provide patients with personalised mRNA cancer immunotherapies by 203...
$Suntec Reit (T82U.SG)$ sgd 1.34. Concern about tech sector slowdown (constituting approx 40% its leasee), high interest rate, high gearing (i.e., debt-to-equity), 30% lease due for renewal. Good points is high occupancy, long-term leases, forex hedged . Strategy anticipated: divest assets to lower debt (ref. 1)
reference
1. https://www.theedgesingapore.com/capital/brokers-calls/rhb-downgrades-suntec-reit-neutral-lower-tp-147
reference
1. https://www.theedgesingapore.com/capital/brokers-calls/rhb-downgrades-suntec-reit-neutral-lower-tp-147
2
skc2021
commented on
$Nanofilm (MZH.SG)$I bought this at $4.30…. still holding it. Too late to dump it now is it?
2
22
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)